Chen Ruiqi, Ning Yichong, Zeng Guirong, Zhou Hao, Zhou Lin, Xiao Pei, Li Zhihong, Zhou Jianlin
Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
J Cancer. 2021 Aug 8;12(19):5903-5913. doi: 10.7150/jca.60969. eCollection 2021.
MiR-193a-5p has been observed to have oncogenic or tumor suppressive functions in different kinds of cancers, but its role and molecular mechanism in osteosarcoma are elusive. Na/Ca exchangers (NCX1, NCX2 and NCX3) normally extrude Ca from the cell, and deregulation of the intracellular Ca homeostasis is related to several kinds of diseases, including cancer. The present study demonstrated that miR-193a-5p was upregulated in osteosarcoma tissues compared with the corresponding adjacent noncancerous tissues, and promoted colony formation, migration, invasion and epithelial-mesenchymal transition (EMT) in osteosarcoma cells (SaOS-2 and U-2OS), as well as metastasis in a murine xenograft model. Tandem mass tag-based quantitative proteomics analysis identified NCX2 as a potential target of miR-193a-5p. Luciferase activity assays and Western blotting further confirmed that miR-193a-5p recognized the 3'-untranslated region of NCX2 mRNA, and negatively regulated NCX2 expression. NCX2 was downregulated in osteosarcoma tissues, and its expression was negatively correlated with miR-193a-5p levels. Ectopic expression of NCX2 in osteosarcoma cells could reverse the oncogenicity of miR-193a-5p, indicating that miR-193a-5p exerted its effects by targeting NCX2. Further study demonstrated that NCX2 suppresses Ca-dependent Akt phosphorylation by decreasing intracellular Ca concentration, and then inhibited EMT process. Treatment with the antagomir against miR-193a-5p sensitized osteosarcoma to the Akt inhibitor afuresertib in a murine xenograft model. In conclusion, a miR-193a-5p/NCX2/AKT signaling axis contributes to the progression of osteosarcoma, which may provide a new therapeutic target for osteosarcoma treatment.
已观察到miR-193a-5p在不同类型的癌症中具有致癌或抑癌功能,但其在骨肉瘤中的作用及分子机制尚不清楚。钠/钙交换蛋白(NCX1、NCX2和NCX3)通常将钙离子从细胞内排出,细胞内钙稳态失调与包括癌症在内的多种疾病相关。本研究表明,与相应的癌旁非癌组织相比,miR-193a-5p在骨肉瘤组织中上调,并促进骨肉瘤细胞(SaOS-2和U-2OS)的集落形成、迁移、侵袭和上皮-间质转化(EMT),以及在小鼠异种移植模型中的转移。基于串联质量标签的定量蛋白质组学分析确定NCX2为miR-193a-5p的潜在靶点。荧光素酶活性测定和蛋白质印迹进一步证实,miR-193a-5p识别NCX2 mRNA的3'-非翻译区,并负向调节NCX2表达。NCX2在骨肉瘤组织中下调,其表达与miR-193a-5p水平呈负相关。在骨肉瘤细胞中异位表达NCX2可逆转miR-193a-5p的致癌性,表明miR-193a-5p通过靶向NCX2发挥作用。进一步研究表明,NCX2通过降低细胞内钙浓度抑制钙依赖性Akt磷酸化,进而抑制EMT过程。在小鼠异种移植模型中,用抗miR-193a-5p的拮抗剂处理可使骨肉瘤对Akt抑制剂阿福司替尼敏感。总之,miR-193a-5p/NCX2/AKT信号轴促进骨肉瘤进展,这可能为骨肉瘤治疗提供新的治疗靶点。